Navigation Links
Osteotech Renews Tissue Recovery Agreement with the Euro Atlantic Transplant Alliance
Date:4/18/2008

system of the European Union."

Dr. Galina V. Balabanova, M.D., Executive Director of the EATA, remarked, "Osteotech and Osteocentre Bulgaria have been excellent partners and supporters of tissue banking in Bulgaria. They have a rich tradition in technological advancement and quality. Osteotech is also a key financial supporter of the collaboration we have with the Scoliosis Research Society, which allows us to provide pediatric spinal deformity surgery for children without healthcare insurance coverage."

The EATA, a public non-profit foundation authorized under the Bulgarian Transplant Law of 2007 and organized under the Bulgarian Public Foundations Law of 2001, is responsible for funding healthcare projects in Bulgaria for the public benefit, tissue transplantation, international patient referral services and pediatric spinal deformity surgery for children without healthcare insurance coverage. The EATA also provides financial management and fundraising to hospitals and providers participating in the Bulgarian national donor recovery network.

Osteotech, Inc., headquartered in Eatontown, New Jersey, is a global leader in providing OsteoBiologic solutions for regenerative medicine to support surgeons and their patients in the repair of the musculoskeletal system through the development of innovative therapy-driven products that alleviate pain, promote biologic healing and restore function. For further information regarding Osteotech, this press release or the conference call, please go to Osteotech's website at http://www.osteotech.com.

Certain statements made throughout this press release that are not historical facts contain forward-looking statements (as such are defined in the Private Securities Litigation Reform Act of 1995) regarding the Company's future plans, objectives and expected performance. Any such forward-looking statements are based on assumptions that the Company believe
'/>"/>

SOURCE Osteotech, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. Osteotech Announces First Quarter Earnings Release and Conference Call Schedule
2. U.S. Patent Office Confirms Validity of Osteotechs U.S. Patent No. 5,676,146
3. Osteotech to Present at the Sidoti Conference in New York
4. Osteotech Receives FDA Clearance for Plexur M(TM) Biocomposite
5. Osteotech to Present at the Canaccord Adams Small-Cap Orthopedics Conference in San Francisco
6. Osteotech Reports 2007 Full Year and Fourth Quarter Financial Results; Full Year Revenue of $104.3 Million Exceeds $100 Million Milestone; Diluted Earnings Per Share Was $.15 in 2007
7. Osteotech Announces Fourth Quarter and Full Year Earnings Release and Conference Call Schedule
8. Osteotech to Present at Sidoti Conference in San Francisco
9. Osteotech to Present at Roth Capital Partners 2007 New York Investor Conference
10. Biomaxx Systems Inc. Renews Membership With Bioenergy Australia
11. Starion Achieves Worldwide Distribution of Proprietary Tissue Welding Technology

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/24/2009)... The New York investment bank KTA Capital,s clie... an AU$6.7 mil convertible note private placement ...acement was arranged by KTA Capital as Neuren,s ex... New York (PRWEB) November 23, 2009 -...ital, LLC ("KTA Capital") has announced ...
(Date:11/24/2009)...S, Nov. 24 Sigma-Aldrich...t the NASDAQ OMX conference on Tuesday, December 1...ested parties may listen via live audio broadcast ...or.sig m a a ldrich.com/ . Users can click t...bout Sigma-Aldrich: Sigma-Aldrich is a leading L...
(Date:11/24/2009)...EO, Calif., Nov. 24 Neur...company focused on developing and commercializing ...hat Anthony DiTonno, President and Chief Executive...al Piper Jaffray Health Care Conference, to be hel...in New York, New York. ,, Mr. DiTonno and Step...
(Date:11/24/2009)...ry efficacy endpoint has been met for patients wit...er, , QUEBEC CITY, Nov. 24 /PRNewswire-FirstC... AEZ) (the "Company"), a global biopharmaceutical ... today announced positive efficacy data from a Pha...jugate, AEZS-108 (formerly AN-152), in patients wi...
Breaking Biology Technology:KTA Capital Arranges an AU$6.7 Million Private Placement by Neuren Pharmaceuticals 2NeurogesX to Present at Piper Jaffray Health Care Conference 2NeurogesX to Present at Piper Jaffray Health Care Conference 3AEterna Zentaris Announces Positive Results for Phase 2 Study with LHRH-Receptor Targeted Cytotoxic Conjugate AEZS-108 in Endometrial Cancer 2AEterna Zentaris Announces Positive Results for Phase 2 Study with LHRH-Receptor Targeted Cytotoxic Conjugate AEZS-108 in Endometrial Cancer 3AEterna Zentaris Announces Positive Results for Phase 2 Study with LHRH-Receptor Targeted Cytotoxic Conjugate AEZS-108 in Endometrial Cancer 4
...1-12 on Wednesday, short of a veto-proof majority,...it is likely that Gov. Jim Doyle will veto the bil...d two Democrats: Sen. Jeff Plale, D-South Milwauke... 499, would outlaw not only cloning for reproducti...tic or research cloning, in which an embryo is cre...
...ormation technology provider IDX Systems Corp. , ...sday. The transaction is expected to close by earl...plementary product lines," said GE Healthcare Vice...er is a very comprehensive product line across rad...both in-patient and physician office electronic he...
...es will receive funding for technology development...chnology Assistance Grant (TAG) and Technology Ven...ollows: , , SonoPlot, Inc. is a Madison company es... It will receive a $100,000 TVF loan to purchase e...king System, LLC, Hortonville, was established in ...
Other Biology Technology:Wisconsin Senate votes to outlaw cloning; measure still faces veto 2Wisconsin Senate votes to outlaw cloning; measure still faces veto 3
(Date:11/26/2009)...thicillin-resistant Staphylococcus Aureus ) and o...on as low-temperature plasma prototype devices hav...failing bactericidal cocktails. , Two prototype ...infection of healthy skin (e.g. hands and feet) in...se a lethal threat; and another to shoot bacteria-...
(Date:11/25/2009)... a hormone produced in the stomach, may be used to...Parkinson,s disease, Yale School of Medicine resea...ue of the Journal of Neuroscience . , Parkinson... neurons in an area of the midbrain known as the s... production. Reduced production of dopamine in la...
(Date:11/25/2009)...mber 11, firefighters, police officers and ambulan... World Trade Center complex. They battled to save ...or survivors, tackled fires and evacuated as many ... estimated 17,000 people. And making their jobs ev...frightened workers and their relatives jammed mobi...
Breaking Biology News(10 mins):Plasma produces KO cocktail for MRSA 2Plasma produces KO cocktail for MRSA 3Hormone ghrelin can boost resistance to Parkinson's disease 2Magic box for mission impossible 2Magic box for mission impossible 3FDA Warns of Unapproved and Illegal H1N1 Drug Products Purchased Over the Internet 59582 1FDA Warns of Unapproved and Illegal H1N1 Drug Products Purchased Over the Internet 59582 2FDA Warns of Unapproved and Illegal H1N1 Drug Products Purchased Over the Internet 59582 3Mayo Clinic Clinicians Develop New Decision Aid Tool to Help Type 2 Diabetes Patients 59578 1Mayo Clinic Clinicians Develop New Decision Aid Tool to Help Type 2 Diabetes Patients 59578 2Mayo Clinic Clinicians Develop New Decision Aid Tool to Help Type 2 Diabetes Patients 59578 3Mayo Clinic Clinicians Develop New Decision Aid Tool to Help Type 2 Diabetes Patients 59578 4Liver Cells Made to Order 59576 1Liver Cells Made to Order 59576 2
...nical report published by the Pacific Northwest Re... of the tourism industry in Hoonah, Alaskaa Tlingi...ast portion of the state. , The report, titled S... describes the development of the tourism industry... on community life and resource use, and presents ...
...2007) -- Alcohol triggers the activation of a vari...ivity of brain cells, and new research from Weill ...ht on how that process occurs. , The findings, pu...roscience, may also edge scientists closer to unde...in damage associated with chronic alcoholism, and ...
... December 15th issue of Biophysical Journal, publi...online. Topics of interest include cardiac contrac...rapping; single-molecule, ADP-bound cross-bridges;...ue 12, December 15, 2007 , , Effects of Sustai...ridge Dynamics in Rat Hearts , , James T Pearson...
Other Biology News:Research reveals secrets of alcohol's effect on brain cells 2Research reveals secrets of alcohol's effect on brain cells 3Media highlights in the Dec. 15 issue of Biophysical Journal 2Media highlights in the Dec. 15 issue of Biophysical Journal 3Media highlights in the Dec. 15 issue of Biophysical Journal 4
Mouse Anti-Human IkBa / MAD-3 Antibody, Unconjugated from Raybiotech, Inc.
PI/RNase Staining Buffer Solution from BD Biosciences Pharmingen
Rabbit Anti-Human Macrophage-stimulating protein receptor Polyclonal Antibody, Unconjugated from GenWay Biotech, Inc.
Mouse Anti-HSV1, HSV2 ICP5 Major Capsid Protein Monoclonal Antibody, Unconjugated, Clone 3B6 from Abcam
Biology Products: